Literature DB >> 22201881

Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure.

Eric W Holroyd1, Thomas A White, Shuchong Pan, Robert D Simari.   

Abstract

Tissue factor pathway inhibitor (TFPI) is a potent regulator of tissue factor - factor VII-dependent activation of the tissue factor pathway. TFPI is a serine protease inhibitor that contains three Kunitz domains and a basic carboxyl terminus. TFPI is primarily expressed on endothelial cells, and murine models have demonstrated that its expression regulates vascular thrombosis. The localization of TFPI expression and the requirement for TFPI in development suggest a potential role in regulating vascular structure. Data from animal studies suggest that vascular expression of TFPI inhibits pathologic vascular remodeling and inhibits angiogenesis. The mechanism for these effects is diverse and includes tissue factor and factor Xa-dependent and -independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201881      PMCID: PMC3904648          DOI: 10.2741/e386

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  63 in total

1.  Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody.

Authors:  R A Fleck; L V Rao; S I Rapaport; N Varki
Journal:  Thromb Res       Date:  1990-07-15       Impact factor: 3.944

2.  Proteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: effect on TFPI activity.

Authors:  A Li; T C Wun
Journal:  Thromb Haemost       Date:  1998-09       Impact factor: 5.249

3.  Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation.

Authors:  A A Belaaouaj; A Li; T C Wun; H G Welgus; S D Shapiro
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

4.  Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.

Authors:  N M Caplice; C S Mueske; L S Kleppe; R D Simari
Journal:  Circulation       Date:  1998-09-15       Impact factor: 29.690

5.  Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.

Authors:  Z F Huang; D Higuchi; N Lasky; G J Broze
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

Review 6.  Tissue factor pathway inhibitor: structure, biology and involvement in disease.

Authors:  Bashir A Lwaleed; Paul S Bass
Journal:  J Pathol       Date:  2006-02       Impact factor: 7.996

7.  Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit.

Authors:  J C Chan; P Carmeliet; L Moons; E D Rosen; Z F Huang; G J Broze; D Collen; F J Castellino
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

8.  Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro.

Authors:  J B Hansen; K R Huseby; N E Huseby; M Ezban; A Nordøy
Journal:  Thromb Res       Date:  1997-03-01       Impact factor: 3.944

9.  Identification of active tissue factor in human coronary atheroma.

Authors:  J D Marmur; S V Thiruvikraman; B S Fyfe; A Guha; S K Sharma; J A Ambrose; J T Fallon; Y Nemerson; M B Taubman
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

10.  Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity.

Authors:  Todd A Hembrough; Jose F Ruiz; Bonnie M Swerdlow; Glenn M Swartz; Hans J Hammers; Li Zhang; Stacy M Plum; Mark S Williams; Dudley K Strickland; Victor S Pribluda
Journal:  Blood       Date:  2004-01-22       Impact factor: 22.113

View more
  4 in total

1.  Levels of TAFI, TFPI and ADAMTS-13 in inflammatory bowel disease.

Authors:  Bilgehan Yüzbaşıoğlu; Müge Ustaoğlu; Şule Yüzbaşıoğlu; Ulaş Emre Akbulut; Kamil Özdil
Journal:  Turk J Gastroenterol       Date:  2019-12       Impact factor: 1.852

2.  Association of Thrombin Generation With Leukocyte Inflammatory Profile in Patients With Acute Ischemic Stroke.

Authors:  Sarina Falcione; Danielle Munsterman; Twinkle Joy; Joseph Kamtchum-Tatuene; Gina Sykes; Glen Jickling
Journal:  Neurology       Date:  2022-07-05       Impact factor: 11.800

3.  Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.

Authors:  German Reyes-Botero; Caroline Dehais; Ahmed Idbaih; Nadine Martin-Duverneuil; Marion Lahutte; Catherine Carpentier; Eric Letouzé; Olivier Chinot; Hugues Loiseau; Jerome Honnorat; Carole Ramirez; Elisabeth Moyal; Dominique Figarella-Branger; François Ducray
Journal:  Neuro Oncol       Date:  2013-12-18       Impact factor: 13.029

4.  Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy.

Authors:  Ahmed M Abu El-Asrar; Mohammad Mairaj Siddiquei; Mohd Imtiaz Nawaz; Gert De Hertogh; Ghulam Mohammad; Kaiser Alam; Ahmed Mousa; Ghislain Opdenakker
Journal:  Mol Vis       Date:  2016-04-30       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.